The global glaucoma therapeutics market size reached US$ 7 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 10.2 Billion by 2027, exhibiting a growth rate (CAGR) of 6.52% during 2022-2027. More Info:- https://www.imarcgroup.com/glaucoma-therapeutics-market

1. Copyright © IMARC Service Pvt Ltd. All Rights Reserved
Global Glaucoma Therapeutics
Market Research and Forecast
Report 2022-2027
Author: Elena Anderson
Marketing Manager
IMARC Group
© 2022 IMARC All Rights Reserved

2. Report Description
About IMARC Group
International Market Analysis Research and Consulting Group is a leading adviser on
management strategy and market research worldwide. We partner with clients in all regions
and industry verticals to identify their highest-value opportunities, address their most critical
challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological
developments for business leaders in pharmaceutical, industrial, and high technology
organizations. Market forecasts and industry analysis for biotechnology, advanced materials,
chemicals, food and beverage, travel and tourism, nanotechnology and novel processing
methods are at the top of the company’s expertise.
IMARC’s tailored approach combines unfathomable insight into the dynamics of companies and
markets with close cooperation at all levels of the client organization. This ensures that our
clients achieve unmatchable competitive advantage, build more proficient organizations, and
secure lasting results.

3. Report Description
Report Description and Highlights
Global Glaucoma Therapeutics Market Research Report 2022-2027:
According to the latest report by IMARC Group, titled "Glaucoma Therapeutics Market: Global
Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027," the global glaucoma
therapeutics market size reached US$ 7 Billion in 2021.
Glaucoma is an ocular disorder that damages the optic nerve of the patient. The structural changes
in the optic nerves are usually caused by the abnormally high intraocular pressure (IOP) due to the
extra build-up of fluid in the front part of the eyes. This condition can often lead to vision loss and
permanent blindness in progressive cases. Numerous medications and therapies are prescribed to
patients with glaucoma in order to avoid complete vision loss.
Eye drops that belong to the class of beta-blockers, alpha agonists, prostaglandins and cholinergic
are usually prescribed to reduce the production of fluid in the eyes. These drops can then be
followed by conventional or laser surgeries for effective results. In several cases, a combination of
both approaches is utilized for the treatment of glaucoma.
Request for a PDF sample of this report: https://www.imarcgroup.com/glaucoma-therapeutics-
market/requestsample

4. Report Description
Report Description and Highlights
Global Glaucoma Therapeutics Market Trends:
The market is primarily driven by the increasing occurrence of glaucoma on the global level. This can be
attributed to the rising number of patients who have diabetes due to their shifting lifestyle patterns and
a lack of physical activities. This, along with the increasing geriatric population that is more susceptible
to chronic ocular disorders, is providing a thrust to the market growth. Along with this, there has been a
growing preference for the adoption of laser glaucoma surgeries among the patients as well as the
healthcare professionals on account of the successful outcomes of this procedure. Multiple
professionals are also prescribing combination therapies for the treatment of glaucoma that involves
the use of polymer-based contact lenses, drug-eluting punctal plugs, implantable extended-release
devices, microneedle-injection devices and micro-dosing technologies.
Coupled with the increasing number of awareness programs conducted by multiple organizations to
spread awareness regarding the availability of effective glaucoma therapeutics, this is creating a positive
outlook for the market. Some of the other factors contributing to the market growth include the
continual research and development (R&D) activities to introduce innovative therapeutics and the
improving healthcare infrastructure across the globe, especially in developing economies.

5. Report Description
Report Description and Highlights
Looking forward, IMARC Group expects the market is expected to grow at a CAGR of 6.52% during
2022-2027.
View Report TOC, Figures and Tables: https://www.imarcgroup.com/glaucoma-therapeutics-market

6. Report Description
Report Description and Highlights
Key Market Segmentation
The research report includes the following segments:
Breakup by Drug Class:
•Prostaglandin Analogs
•Beta Blockers
•Alpha Adrenergic Agonists
•Carbonic Anhydrase Inhibitors
•Combination Drugs
•Others
Breakup by Indication:
•Open Angle Glaucoma
•Angle Closure Glaucoma
•Others
Breakup by End User:
•Hospitals
•Ophthalmic Clinics

7. Report Description
Report Description and Highlights
•Ambulatory Surgery Centers
•Others
Breakup by Region:
•North America
•Asia Pacific
•Europe
•Latin America
•Middle East and Africa

8. Report Description
Report Description and Highlights
Competitive Landscape with Key Players:
•Aerie Pharmaceuticals Inc
•Allergan Plc
•Bausch & Lomb Incorporated (Bausch Health Companies Inc.)
•Inotek Pharmaceuticals Corp
•Merck & Co. Inc
•Novartis AG
•Pfizer Inc
•Santen Pharmaceutical Co. Ltd
•SIFI S.p.A
•Teva Pharmaceutical Industries Ltd

9. Report Description
Key Questions Answered in the Report
1. How has the global glaucoma therapeutics market performed so far and how will it perform in
the coming years?
2. What has been the impact of COVID-19 on the global glaucoma therapeutics market?
3. What are the key regional markets?
4. What is the breakup of the market based on the drug class?
5. What is the breakup of the market based on the indication?
6. What is the breakup of the market based on the end user?
7. What are the various stages in the value chain of the industry?
8. What are the key driving factors and challenges in the industry?
9. What is the structure of the global glaucoma therapeutics market and who are the key players?
10. What is the degree of competition in the industry?

10. Report Description Table of Contents
1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Glaucoma Therapeutics Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast

11. Report Description Table of Contents
6 Market Breakup by Drug Class
6.1 Prostaglandin Analogs
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Beta Blockers
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Alpha Adrenergic Agonists
6.3.1 Market Trends
6.3.2 Market Forecast
6.4 Carbonic Anhydrase Inhibitors
6.4.1 Market Trends
6.4.2 Market Forecast
6.5 Combination Drugs
6.5.1 Market Trends
6.5.2 Market Forecast
Click here to visit the complete table of content with list of figures and tables:
https://www.imarcgroup.com/glaucoma-therapeutics-market/toc

12. A partial List of our Clients
We are the trusted business partners to the
world's leading corporates, governments, and
institutions
Partial List of Clients

13. A partial List of our Clients
We are the trusted business partners to the
world's leading corporates, governments, and
institutions
Partial List of Clients

14. Report Description
Report Description and Highlights
© 2022 IMARC All Rights Reserved
This Publication and all it’s contents unless otherwise mentioned are copyrighted in the name of
International Market Analysis Research and Consulting (IMARC). No part of this publication may be
reproduced, repackaged, redistributed or resold in whole or in any part. The publication may also not be
used in any form or by and means graphic electronic or mechanical, including photocopying, recording,
taping or by information storage or retrieval, or by any other form, without the express consent of
International Market Analysis Research and Consulting (IMARC).
Disclaimer: All contents and data of this publication, including forecasts, data analysis and opinion have been
based on information and sources believed to be accurate and reliable at the time of publishing.
International Market Analysis Research and Consulting makes no representation of warranty of any kind as to
the accuracy or completeness of any Information provided. IMARC accepts no liability whatsoever for any
loss or damage resulting from opinion, errors or inaccuracies if any found this publication.
IMARC, IMARC Group and Global Therapy Insight Series are registered trademarks of International Market
Analysis Research and Consulting. All other trademarks used in this publication are registered trademarks of
their respective companies.

15. FOR MORE DETAILS
Visit us at :
Stay With Us:
TELEPHONE: +1-631-791-1145
E-MAIL: sales@imarcgroup.com
https://www.imarcgroup.com
Contact Us